Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis

Huayue Cong; Aixia Sui; Liuyi Yang; Huiling Song; Jing Zhao; Yong Liu; Mingming Zhang; Weiliang He

doi:doi:10.11648/j.crj.20210903.12

| Peer-Reviewed

Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis

Huayue Cong, Aixia Sui, Liuyi Yang, Huiling Song, Jing Zhao, Yong Liu, Mingming Zhang, Weiliang He

Published in Cancer Research Journal (Volume 9, Issue 3)

Received: 20 June 2021 Accepted: 30 June 2021 Published: 7 July 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background and objective: Inflammatory factors are associated with tumour initiation, progression, invasion, and metastasis. It is a potential prognostic factor for multiple solid tumours. Such as cholangiocarcinoma, bladder cancer, nasopharyngeal carcinoma and so on. However, there is no clear evidence that elevation of the systemic inflammatory marker, platelet-to-lymphocyte ratio (PLR), has this type of predictive value in patients with glioma. This meta-analysis aimed to explored the prognostic significance of the preoperative inflammatory marker PLR in patients with glioma. Methods: Systematic retrieval of articles published between the time of their conception and September 2020 in PubMed, EMBASE, and Cochrane library databases, A meta-analysis was performed via Review Manager 5.3, using the hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival (OS) to assess the predictive significance of PLR in patients with glioma. Result: We selected nine studies and showed that in patients with glioma, increased PLR was correlated with poor OS (HR = 1.37, 95% CI: 1.09–1.71, P = 0.007, I² = 55%). By analysing the I², we estimated moderate heterogeneity in several of the published articles that were incorporated. Conclusion: Our meta-analysis provides evidence that increased PLR is correlated with poor OS in patients with glioma cancer.

Published in	Cancer Research Journal (Volume 9, Issue 3)
DOI	10.11648/j.crj.20210903.12
Page(s)	140-147
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Glioma, Platelet to Lymphocyte Ratio, Meta-analysis, Overall Survival

References

[1]	Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018; 392: 432–446.
[2]	Liu M, Wang L. Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio, and prognostic nutritional index for patients with glioma: A meta-analysis. Medicine (Baltimore). 2020; 99 (27): e20927
[3]	Lei Y Y, Li Y T, Hu Q L, Wang J, and Sui A X. Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis. World J Surg Oncol. 2019; 17 (1): 152.
[4]	Hu X, Yan P, Feng J, Zhang F. Expression of microRNA-210 and the prognosis in glioma patients: a meta-analysis. Biomark Med. 2020; 14 (9): 795-805.
[5]	Jiao R, Jiang W, Wei X, Huang G. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis. BMC Cancer. 2020; 20 (1): 662.
[6]	Fang SX, Chen C, Guo Q, et al. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis. Biosci Rep. 2020; 40 (7): 1-17.
[7]	Wang QP, Lei DQ, Yuan Y, Xiong NX. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis. Medicine (Baltimore). 2020; 99 (8): e19254.
[8]	Hu G, Liu Q, Ma JY, Liu CY. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis. Biomed Res Int. 2018: 73-75.
[9]	Wang X, Ni X, Tang G. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis. Front Oncol. 2019; 9: 757.
[10]	Zhang J, Feng W, Ye Z, Yang Y. Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis. Future Oncol. 2020; 16 (5): 117-127.
[11]	Zhang X, Zhao W, Yu Y, Yang L. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020; 18 (1): 191.
[12]	Bao Y, Wang Y, Li X, Wang X. Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis. Cancer Cell Int. 2019; 19: 315.
[13]	Zhang Y, Zheng L, Quan L, Du L. Prognostic role of platelet-to-lymphocyte ratio in oral cancer: A meta-analysis. J Oral Pathol Med. 2019.
[14]	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151: 264–9. w264.
[15]	Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25 (9): 603–5.
[16]	Yunfei Hao, Xiaoli Li, Hecheng Chen, Hongzhi Huo, Zongbao Liu, Fei Tian. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme. Erqing Chai World Neurosurg. 2019; 128: 427-433.
[17]	Lv Y, Zhang S, Liu Z, et al. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma. Clin Neurol Neurosurg. 2019; 181: 24-27.
[18]	Bao Y, Yang M, Jin C, et al. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. World Neurosurg. 2018; 119: 710-716.
[19]	ÖZLEM YERSAL1, EYLEM ODABAŞI2, ÖZGE ÖZDEMIR2 and YASEMIN KEMAL3. Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioblastoma. Mol Clin Oncol. 2018; 9 (4): 453-458.
[20]	Wang PF, Meng Z, Song HW, et al. Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival. Front Pharmacol. 2018; 9: 886.
[21]	Junli Wang, Wenjing Xiao, Wanyi Chen, Yonghe Hu. Prognostic significance of preoperative neutrophilto- lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma. EXCLI Journal. 2018; 17: 505-512.
[22]	Wang PF, Song HW, Cai HQ, et al. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. 2017; 8 (30): 50117-50123.
[23]	Han S, Liu Y, Li Q, et al. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer. 2015; 15: 617.
[24]	Alessandra Marini, Mauro Dobran, Denis Aiudi, Alessandro Pesaresi, Lucia Giovanna Maria di Somma, Maurizio Iacoangeli. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas. Clinical Neurology and Neurosurgery 2020; 10 (6): 162-197.
[25]	Jiang S, Liu J, Chen X, et al. Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis. Arch Gynecol Obstet. 2019; 300 (4): 829-839.
[26]	Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, et al. The association of pretreatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol. 2013; 114: 149-154.
[27]	Scărlătescu E, Lancé MD, White NJ, Aramă SS, Tomescu DR. Effects of malignancy on blood coagulation in septic intensive care patients. Blood Coagul Fibrinolysis. 2018; 29.
[28]	Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017; 117: 219–230.
[29]	Bambace NM, Holmes CE. The platelet contribution to cancer progression. Thromb Haemost. 2011; 9: 237–249.
[30]	Zhang ZY, Zhan YB, Zhang FJ, et al. Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas. Aging (Albany NY). 2019; 11 (16): 6252-6272.
[31]	Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011; 105 (1): 93–103.
[32]	T. K. Hoffmann, G. Dworacki, T. Tsukihiro et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clinical Cancer Research. 2002; 8: 2553–2562.
[33]	J. P. V ayrynen, A Tuomisto, K Klintrup, J M akela, T J Karttunen, and M J M akinen. Detailed analysis of inflammatory cell infiltration in colorectal cancer. British Journal of Cancer. 2013; 109 (7): 1839–1847.

Cite This Article

Plain Text BibTeX RIS

APA Style

Huayue Cong, Aixia Sui, Liuyi Yang, Huiling Song, Jing Zhao, et al. (2021). Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Research Journal, 9(3), 140-147. https://doi.org/10.11648/j.crj.20210903.12

Copy | Download

ACS Style

Huayue Cong; Aixia Sui; Liuyi Yang; Huiling Song; Jing Zhao, et al. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Res. J. 2021, 9(3), 140-147. doi: 10.11648/j.crj.20210903.12

Copy | Download

AMA Style

Huayue Cong, Aixia Sui, Liuyi Yang, Huiling Song, Jing Zhao, et al. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Res J. 2021;9(3):140-147. doi: 10.11648/j.crj.20210903.12

Copy | Download

@article{10.11648/j.crj.20210903.12,
  author = {Huayue Cong and Aixia Sui and Liuyi Yang and Huiling Song and Jing Zhao and Yong Liu and Mingming Zhang and Weiliang He},
  title = {Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis},
  journal = {Cancer Research Journal},
  volume = {9},
  number = {3},
  pages = {140-147},
  doi = {10.11648/j.crj.20210903.12},
  url = {https://doi.org/10.11648/j.crj.20210903.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20210903.12},
  abstract = {Background and objective: Inflammatory factors are associated with tumour initiation, progression, invasion, and metastasis. It is a potential prognostic factor for multiple solid tumours. Such as cholangiocarcinoma, bladder cancer, nasopharyngeal carcinoma and so on. However, there is no clear evidence that elevation of the systemic inflammatory marker, platelet-to-lymphocyte ratio (PLR), has this type of predictive value in patients with glioma. This meta-analysis aimed to explored the prognostic significance of the preoperative inflammatory marker PLR in patients with glioma. Methods: Systematic retrieval of articles published between the time of their conception and September 2020 in PubMed, EMBASE, and Cochrane library databases, A meta-analysis was performed via Review Manager 5.3, using the hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival (OS) to assess the predictive significance of PLR in patients with glioma. Result: We selected nine studies and showed that in patients with glioma, increased PLR was correlated with poor OS (HR = 1.37, 95% CI: 1.09–1.71, P = 0.007, I2 = 55%). By analysing the I2, we estimated moderate heterogeneity in several of the published articles that were incorporated. Conclusion: Our meta-analysis provides evidence that increased PLR is correlated with poor OS in patients with glioma cancer.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis
AU  - Huayue Cong
AU  - Aixia Sui
AU  - Liuyi Yang
AU  - Huiling Song
AU  - Jing Zhao
AU  - Yong Liu
AU  - Mingming Zhang
AU  - Weiliang He
Y1  - 2021/07/07
PY  - 2021
N1  - https://doi.org/10.11648/j.crj.20210903.12
DO  - 10.11648/j.crj.20210903.12
T2  - Cancer Research Journal
JF  - Cancer Research Journal
JO  - Cancer Research Journal
SP  - 140
EP  - 147
PB  - Science Publishing Group
SN  - 2330-8214
UR  - https://doi.org/10.11648/j.crj.20210903.12
AB  - Background and objective: Inflammatory factors are associated with tumour initiation, progression, invasion, and metastasis. It is a potential prognostic factor for multiple solid tumours. Such as cholangiocarcinoma, bladder cancer, nasopharyngeal carcinoma and so on. However, there is no clear evidence that elevation of the systemic inflammatory marker, platelet-to-lymphocyte ratio (PLR), has this type of predictive value in patients with glioma. This meta-analysis aimed to explored the prognostic significance of the preoperative inflammatory marker PLR in patients with glioma. Methods: Systematic retrieval of articles published between the time of their conception and September 2020 in PubMed, EMBASE, and Cochrane library databases, A meta-analysis was performed via Review Manager 5.3, using the hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival (OS) to assess the predictive significance of PLR in patients with glioma. Result: We selected nine studies and showed that in patients with glioma, increased PLR was correlated with poor OS (HR = 1.37, 95% CI: 1.09–1.71, P = 0.007, I2 = 55%). By analysing the I2, we estimated moderate heterogeneity in several of the published articles that were incorporated. Conclusion: Our meta-analysis provides evidence that increased PLR is correlated with poor OS in patients with glioma cancer.
VL  - 9
IS  - 3
ER  -

Copy | Download

Author Information

Huayue Cong

Hebei General Hospital, Shijiazhuang, China
Aixia Sui

Hebei General Hospital, Shijiazhuang, China
Liuyi Yang

Hebei General Hospital, Shijiazhuang, China
Huiling Song

Hebei General Hospital, Shijiazhuang, China
Jing Zhao

Hebei General Hospital, Shijiazhuang, China
Yong Liu

Department of Oncology, Baoding First Central Hospital, Baoding, China
Mingming Zhang

Hebei General Hospital, Shijiazhuang, China
Weiliang He

Hebei General Hospital, Shijiazhuang, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Huayue Cong, Aixia Sui, Liuyi Yang, Huiling Song, Jing Zhao, et al. (2021). Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Research Journal, 9(3), 140-147. https://doi.org/10.11648/j.crj.20210903.12

Copy | Download

ACS Style

Huayue Cong; Aixia Sui; Liuyi Yang; Huiling Song; Jing Zhao, et al. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Res. J. 2021, 9(3), 140-147. doi: 10.11648/j.crj.20210903.12

Copy | Download

AMA Style

Huayue Cong, Aixia Sui, Liuyi Yang, Huiling Song, Jing Zhao, et al. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis. Cancer Res J. 2021;9(3):140-147. doi: 10.11648/j.crj.20210903.12

Copy | Download

@article{10.11648/j.crj.20210903.12,
  author = {Huayue Cong and Aixia Sui and Liuyi Yang and Huiling Song and Jing Zhao and Yong Liu and Mingming Zhang and Weiliang He},
  title = {Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis},
  journal = {Cancer Research Journal},
  volume = {9},
  number = {3},
  pages = {140-147},
  doi = {10.11648/j.crj.20210903.12},
  url = {https://doi.org/10.11648/j.crj.20210903.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20210903.12},
  abstract = {Background and objective: Inflammatory factors are associated with tumour initiation, progression, invasion, and metastasis. It is a potential prognostic factor for multiple solid tumours. Such as cholangiocarcinoma, bladder cancer, nasopharyngeal carcinoma and so on. However, there is no clear evidence that elevation of the systemic inflammatory marker, platelet-to-lymphocyte ratio (PLR), has this type of predictive value in patients with glioma. This meta-analysis aimed to explored the prognostic significance of the preoperative inflammatory marker PLR in patients with glioma. Methods: Systematic retrieval of articles published between the time of their conception and September 2020 in PubMed, EMBASE, and Cochrane library databases, A meta-analysis was performed via Review Manager 5.3, using the hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival (OS) to assess the predictive significance of PLR in patients with glioma. Result: We selected nine studies and showed that in patients with glioma, increased PLR was correlated with poor OS (HR = 1.37, 95% CI: 1.09–1.71, P = 0.007, I2 = 55%). By analysing the I2, we estimated moderate heterogeneity in several of the published articles that were incorporated. Conclusion: Our meta-analysis provides evidence that increased PLR is correlated with poor OS in patients with glioma cancer.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Prognostic Significance of Platelet-to-Lymphocyte Ratio in Gliomas: A Meta-analysis
AU  - Huayue Cong
AU  - Aixia Sui
AU  - Liuyi Yang
AU  - Huiling Song
AU  - Jing Zhao
AU  - Yong Liu
AU  - Mingming Zhang
AU  - Weiliang He
Y1  - 2021/07/07
PY  - 2021
N1  - https://doi.org/10.11648/j.crj.20210903.12
DO  - 10.11648/j.crj.20210903.12
T2  - Cancer Research Journal
JF  - Cancer Research Journal
JO  - Cancer Research Journal
SP  - 140
EP  - 147
PB  - Science Publishing Group
SN  - 2330-8214
UR  - https://doi.org/10.11648/j.crj.20210903.12
AB  - Background and objective: Inflammatory factors are associated with tumour initiation, progression, invasion, and metastasis. It is a potential prognostic factor for multiple solid tumours. Such as cholangiocarcinoma, bladder cancer, nasopharyngeal carcinoma and so on. However, there is no clear evidence that elevation of the systemic inflammatory marker, platelet-to-lymphocyte ratio (PLR), has this type of predictive value in patients with glioma. This meta-analysis aimed to explored the prognostic significance of the preoperative inflammatory marker PLR in patients with glioma. Methods: Systematic retrieval of articles published between the time of their conception and September 2020 in PubMed, EMBASE, and Cochrane library databases, A meta-analysis was performed via Review Manager 5.3, using the hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival (OS) to assess the predictive significance of PLR in patients with glioma. Result: We selected nine studies and showed that in patients with glioma, increased PLR was correlated with poor OS (HR = 1.37, 95% CI: 1.09–1.71, P = 0.007, I2 = 55%). By analysing the I2, we estimated moderate heterogeneity in several of the published articles that were incorporated. Conclusion: Our meta-analysis provides evidence that increased PLR is correlated with poor OS in patients with glioma cancer.
VL  - 9
IS  - 3
ER  -

Copy | Download